Partner Headlines - LLY

  1. Roche Drugs For Alzheimer's, Breast Cancer Disappoint

    IBD
  2. 7 Stocks You Should Be Watching Today

    Benzinga
  3. Eli Lilly

    IBD
  4. Lilly Upgraded On 2 Potential Blockbuster Drugs

    IBD
  5. Alexandria Real Estate REIT Inks Rx For Pharma Boom

    IBD
  6. Biogen Alzheimer's Drug Succeeding In Early Tests

    IBD
  7. Zosano Pharma and Eli Lilly and Company Enter Into Exclusive ...

    Benzinga
  8. Sanofi's Bullish Pipeline Forecast Underwhelms Street

    IBD
  9. Screening Pharma Stocks Amid Turnaround

    YCharts
  10. Sarah Ketterer Dives in when Others Pull Out

    GuruFocus
  11. Credit Suisse Raises Eli Lilly Price Target

    Benzinga
  12. Veeva Systems Flies High On Cloud For Life Sciences

    IBD
  13. Sanofi Axes CEO, Hit By Multiple Downgrades

    IBD
  14. French Drugmaker Sanofi Warns Of Tougher Competition

    IBD
  15. US Stock Futures Rise Ahead Of Earnings, Economic Data

    Benzinga
  16. Earnings Scheduled For October 23, 2014

    Benzinga
  17. CANDA NK-2 Files Motion To Dismiss Patent Infringement Suit

    Benzinga
  18. Lilly, Zymeworks Announce Expansion Of Strategic Licensing And ...

    Benzinga
  19. Benzinga Weekly Preview: Earnings Season Is In Full Swing

    Benzinga
  20. Celgene, Alexion Among 4 IBD 50 Medical s To Report

    IBD
  21. UPDATE: Lilly To Initiate Efforts To Sell Guayama Site

    Benzinga
  22. Lilly Announces Plan to Realign Puerto Rico Manufacturing Operations

    Benzinga
  23. Drug Analysts Mull End Of 'Double Irish' Loophole

    IBD
  24. Pharma Stocks: Surprising Shift In U.S. Drug Market

    YCharts
  25. Meet 5 Top International Stocks Not Based In China

    IBD
  26. Dyax Offers Highlights of Recent Progress in Licensing, Funded-Research ...

    Benzinga
  27. Lipocine Inc Halted: Feds Eye Safety, Efficacy Of Testosterone

    Benzinga
  28. Drug giants target Alzheimer's

    IBD
  29. What Is A High Risk Market?

    Benzinga
  30. Higher Yielding Stocks With A Cheap EV/EBITDA Ratio And Low Debt ...

    GuruFocus
  31. Markets Little Changed In Low Volume And Slow News Ahead Of Long ...

    Benzinga
  32. Deutsche Bank: Eli Lilly At 'Critical Stage' In Its Journey

    Benzinga
  33. Deutsche Bank Starts Pfizer, Lilly at Buy, Merck, Bristol-Myers ...

    Benzinga
  34. New Type 2 Diabetes Treatment Jardiance Tablets For Adults Now ...

    Benzinga
  35. UPDATE: Tigress Initiates Coverage On Eli Lilly

    Benzinga
  36. Dow Suffers 300 Point Drop; S&P 500 And Nasdaq Also Tumble

    Benzinga
  37. Stocks Lower As Earnings Season Takes Back Seat To Geopolitical ...

    Benzinga
  38. Thursday Morning Earnings Reports

    Benzinga
  39. Earnings Scheduled For July 24, 2014

    Benzinga
  40. New Study Shows Beta-Amyloid Imaging Is Associated With Altered ...

    Benzinga
  41. Lilly And Immunocore Enter Immunotherapy Agreement To Co-Discover ...

    Benzinga
  42. Benzinga's Top #PreMarket Gainers

    Benzinga
  43. US Stock Futures Mostly Higher Ahead Of Goldman Sachs Earnings

    Benzinga
  44. Barclays Downgrades Pharmaceutical Sector

    Benzinga
  45. UPDATE: Barclays Upgrades Eli Lilly Despite Sector Downgrade

    Benzinga
  46. Benzinga's Top Upgrades

    Benzinga
  47. Eli Lilly is on the Right Track

    GuruFocus
  48. Celgene Sees Better Results For Psoriatic Arthritis

    IBD
  49. Eli Lilly Bets Big on Diabetes, Cancer Drugs

    FoxBusiness
  50. Novo Nordisk Raises Insulin Prices As Demand Grows

    IBD
  51. ASCO Meeting Day 3: Do More Treatments Equal A Longer Life?

    Benzinga
  52. ASCO Meeting Day 2: 'Promising' Results From JNJ's Imbruvica ...

    Benzinga
  53. John Paulson's 4 Stocks Trading for Less Than He Paid for Them

    GuruFocus
  54. Lilly Says Abemaciclib in Phase 1 Study Demonstrated Single-Agent ...

    Benzinga
  55. Eli Lilly insulin trial succeeds

    IBD
  56. Cross-Border Megamergers Drive Global Takeover Boom

    IBD
  57. Google Celebrates Dorothy Hodgkin & Her Contributions To Chemistry

    Benzinga
  58. Eli Lilly's Basal Insulin Outperforms Lantus In Trial

    IBD
  59. UPDATE: Eli Lilly Announces Peglispro Shows Superiority Compared ...

    Benzinga
  60. Can Pfizer Make Up Its Loss?

    GuruFocus
  61. Merck Sells Consumer Unit To Bayer To Focus On R&D

    IBD
  62. Bayer Buys Merck Consumer Care Unit

    FoxBusiness
  63. Will Pfizer's Q1 2014 Earnings Beat the Street on May 5, 2014?

    GuruFocus
  64. AstraZeneca Rejects Pfizer's $106B Buyout Bid

    FoxBusiness
  65. Novo Nordisk Struggles In U.S. Market; Q1 Sales Miss

    IBD
  66. Novo Nordisk Q1 Revenue Misses; Guidance Lowered

    IBD
  67. Vanguard Health Care Fund's Top Quarterly Holdings

    GuruFocus
  68. Actavis Earns Over-The-Top Q1

    IBD
  69. Actavis Beats Q1 Views, Looks To Supersized Future

    IBD
  70. Actavis Q1 Earnings Beat On Generic Cymbalta Surprise

    IBD
  71. China Rule Change Further Opens Yuan To World Markets

    IBD
  72. These Three Pharmaceutical Companies Shake The Market With Their ...

    GuruFocus
  73. Drugmakers' Q1 was anemic

    IBD
  74. Eli Lilly Jr. Made His Firm A Pharmaceutical Power

    IBD
  75. Earnings Scheduled For April 24, 2014

    Benzinga
  76. Big Pharmas Swap Specialties

    IBD
  77. Drugmakers Prod European Stocks To Post-Easter Rally

    IBD
  78. Benzinga's M&A Chatter for Tuesday April 22, 2014

    Benzinga
  79. Novartis, Glaxo Swap Units; Valeant Bids For Allergan

    IBD
  80. Stocks Rise In Higher Volume; Gilead Up After Hours

    IBD
  81. Pharma Deal Frenzy: A Bid to Boost Profits, Cut Risk

    FoxBusiness
  82. Amgen Slumps After 1Q Earnings Miss

    FoxBusiness
  83. Novartis, Glaxo Swap Units; Lilly Buying Animal Biz

    IBD
  84. Stock Futures Mixed And Busy; Allergan, Netflix, Glaxo Climb

    IBD
  85. Novartis Announces Multi-Billion-Dollar Revamp

    FoxBusiness
  86. US Stock Futures Edge Higher Ahead Of McDonald's Earnings

    Benzinga
  87. Stock Futures Steady Amid Raft of Health M&A

    FoxBusiness
  88. Wall Street Ticks Up as Traders Parse News Deluge

    FoxBusiness
  89. ELI LILLY

    IBD
  90. No Legwork Mondays – Takeda, Eli Lilly, And Actos

    Benzinga
  91. Market Wrap For April 14: Markets Surge on Positive Retail Data, ...

    Benzinga
  92. Lilly, Takeda must pay $9 bil

    IBD
  93. Ethical Drug Stocks Are Struggling

    IBD
  94. UPDATE: BMO Capital Upgrades Eli Lilly

    Benzinga
  95. Takeda, Lilly to 'Vigorously Challenge' Actos Ruling

    FoxBusiness
  96. Benzinga's Top Upgrades

    Benzinga
  97. Takeda Responds to $6B Verdict in Diabetes Drug Case

    Benzinga
  98. Top 4 NYSE Stocks In The Drug Manufacturers-Major Industry With ...

    Benzinga
  99. Pfizer Breast-Cancer Drug Scores, But Street Cautious

    IBD
  100. Market Wrap For April 3: Markets Winning Streak Fails To Extend ...

    Benzinga
Trading Center